Haemonetics
HAE
Haemonetics (HAE) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Mizuho | Maintained | Outperform | $140.00 from $95.00 | Oct 9, 2026 |
| Barrington Research | Maintained | Outperform | $140.00 from $118.00 | Oct 9, 2026 |
| BTIG | Maintained | Buy | $130.00 from $110.00 | Oct 8, 2026 |
| Citigroup | Upgraded | Neutral → Buy | $123.00 from $92.00 | Sep 17, 2026 |
| Raymond James | Maintained | Outperform | $125.00 from $105.00 | Sep 3, 2026 |
| Baird | Maintained | Outperform | $119.00 from $96.00 | Aug 21, 2026 |
| Barrington Research | Maintained | Outperform | $118.00 from $95.00 | Aug 19, 2026 |
| BTIG | Maintained | Buy | $110.00 from $96.00 | Aug 18, 2026 |
| JP Morgan | Maintained | Neutral | $86.00 from $62.00 | Aug 7, 2026 |
| Citigroup | Maintained | Neutral | $92.00 from $79.00 | Aug 7, 2026 |
| BTIG | Maintained | Buy | $96.00 from $84.00 | Aug 6, 2026 |
| Mizuho | Maintained | Outperform | $90.00 from $85.00 | Jul 15, 2026 |
| BTIG | Maintained | Buy | $84.00 | Jun 26, 2026 |
| BTIG | Maintained | Buy | $84.00 | Jun 17, 2026 |
| Mizuho | Maintained | Outperform | $85.00 from $70.00 | Jun 15, 2026 |
| Citigroup | Maintained | Neutral | $70.00 from $64.00 | May 28, 2026 |
| B of A Securities | Upgraded | Neutral → Buy | $80.00 from $72.00 | May 22, 2026 |
| Barrington Research | Maintained | Outperform | $89.00 from $94.00 | May 12, 2026 |
| JP Morgan | Maintained | Neutral | $62.00 from $74.00 | May 8, 2026 |
| Mizuho | Maintained | Outperform | $70.00 from $80.00 | Apr 13, 2026 |
Frequently asked questions
What is the latest analyst rating on HAE?
On Oct 9, 2026, Mizuho maintained Haemonetics at Outperform with a price target of $140.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.